“She is a rising star in equity capital markets.”Chambers USA 2021

Alison A. Haggerty

New York
  • 1271 Avenue of the Americas
  • New York, NY 10020
  • USA

Ali Haggerty advises issuers and investment banking firms in capital markets transactions, with a focus on initial public offerings, follow-on equity offerings, and convertible debt offerings in growth industries.

Ms. Haggerty serves a mix of companies and financial institutions in connection with complex equity and debt securities offerings. She brings particular experience handling capital markets transactions on behalf of all of the major US investment banks and leading innovators in technology and the life sciences.

Ms. Haggerty also regularly counsels publicly traded companies on general corporate and securities law matters, including governance issues, reporting obligations, and stock exchange rules and requirements. 

Ms. Haggerty’s representative experience includes advising the issuer or underwriters in connection with securities offerings for the following companies:

  • ADC Therapeutics
  • Aquantia
  • Axovant
  • Cara Therapeutics
  • Catabasis
  • Datadog
  • Duolingo
  • Etsy
  • European Wax Center
  • Everyday Health
  • FIGS
  • Fluence Energy
  • Imara
  • Immunovant
  • MongoDB
  • Monte Rosa
  • Myovant Sciences
  • Ovid
  • Prevail Therapeutics
  • Progyny
  • RenalytixAI
  • Rivian
  • Schrodinger
  • Strongbridge Biopharma
  • WAVE Life Sciences
  • Zentalis Pharmaceuticals

*Certain matters above were handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.